Marcel Patek

NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA.

SymphonyAI Sensa LLC develops interactive analysis and visualization software. Its technology is used to discover new drug therapies, uncover the causes of diseases, root out financial fraud, accelerate energy exploration, discover customer segmentation and complement other Big Data solutions. The company was founded by Gurjeet Singh, Gunnar Carlson and Harlan Sexton in 2008 and is headquartered in Menlo Park, CA.

Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions.

The American company was founded by Nick Johnson, Cheng Zhang, and Marcel van der Brug, with Cheng Zhang serving as the CEO since incorporation. Character Biosciences is focused on developing therapies for ophthalmic and other progressive polygenic diseases. The company has developed a platform that integrates genomics with longitudinal clinical data to select drug targets and match therapies to the right patients. Currently, Character Biosciences is advancing two lead drug discovery programs through preclinical development for dry age-related macular degeneration.

Silverware Software LLC develops mobile applications.

Part of X Holdings Corp., Ubalo, Inc. provides micro blogging services. The company is based in Palo Alto, CA. Ubalo was acquired by X Corp. (United States) on May 09, 2013.

OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT.

The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Hoy Health LLC is a private company founded in 2017 that operates as a platform for online medications and healthcare professional consultation. The company is based in Morristown, NJ and has subsidiaries in the United States.

Innovation Endeavors LLC (Innovation Endeavors) is a venture capital firm founded in 2010 by Dror Berman and Eric E. Schmidt. The firm is headquartered in Palo Alto, California.

Concord Health Partners LLC (Concord Health Partners) is a venture capital firm founded in 2017 by Joseph Swedish and James Olsen. The firm headquartered in Summit, New Jersey.

Scientia Ventures LLC (Scientia Ventures) is a venture capital firm founded in 2006 by Jonathan Finn. The firm is headquartered in New York.